A. Greninger

Age-dependent heterogeneity in the antigenic effects of mutations to influenza hemagglutinin

Frederick A. Matsen IV, Jared G. Galloway, Timothy C. Yu, 2023, bioRxiv.

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features

Lindsay N. Carpp, Bethany L. Dearlove, Allan C. deCamp, 2024, Nature communications.

Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8^+ T cells in persons with previous COVID-19

T. Pulliam, E. Postnikova, H. Robins, 2023, Nature immunology.

Influenza A virus resistance to 4’-fluorouridine coincides with viral attenuation in vitro and in vivo

Jeong-Joong Yoon, R. Cox, M. Natchus, 2024, PLoS pathogens.

Multi-center clinical evaluation of the Panther Fusion SARS-CoV-2/Flu A/B/RSV assay in nasopharyngeal swab specimens from symptomatic individuals

C. V. Remillard, R. Selvarangan, M. Faron, 2023, Journal of clinical microbiology.

Functional and structural basis of human parainfluenza virus type 3 neutralization with human monoclonal antibodies.

T. Jardetzky, A. Moscona, E. Binshtein, 2024, Nature microbiology.

Bright New Resources for Syphilis Research: Genetically Encoded Fluorescent Tags for Treponema pallidum and Sf1Ep Cells.

B. Molini, L. Tantalo, N. Lieberman, 2024, Molecular microbiology.